Clinical Trials Logo

Pressure Ulcers clinical trials

View clinical trials related to Pressure Ulcers.

Filter by:

NCT ID: NCT01166828 Withdrawn - Spinal Cord Injury Clinical Trials

Pressure Ulcer Prevention for SCI Using a Tele Home Program

TELEPUPPS
Start date: January 2011
Phase: N/A
Study type: Interventional

NRI research focuses on nursing interventions that are patient-centered, culturally congruent, cost-effective and outcome-driven. High priority populations of interest are veterans with Spinal Cord Injuries (SCI). The development of innovative tele home techniques for preventing pressure ulcers in veterans with SCI is of high importance in the VA. Our findings may provide clinicians with improved methods for skin and wound assessment and more effective and efficient PUP strategies for Hispanic and non Hispanic veterans. The new model for primary care, the patient-centered Medical Home provides an exciting change in the VA that can benefit from the proposed project.

NCT ID: NCT01139879 Completed - Pressure Ulcers Clinical Trials

P400 for Stage II-IV Pressure Ulcers in Home and Extended Care

P400
Start date: June 2010
Phase: N/A
Study type: Interventional

To assess the efficacy of a pressure ulcer treatment mattress, the P400 mattress, in the treatment of multiple Stage II or one or more large Stage III or IV pressure ulcers in the home care and extended care (nursing home) environment.

NCT ID: NCT01113658 Withdrawn - Clinical trials for Diabetic Foot Ulcers

Clinical Evaluation of the SNaP Wound Care System

Start date: March 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of design improvements of the Spiracur SNaP Wound Care System. This study prospectively evaluates the safety and efficacy of current and new design iterations of components of the FDA-cleared Spiracur SNaP Wound Care System in order to optimize safety, efficacy, and system performance.

NCT ID: NCT01107197 Completed - Pressure Ulcers Clinical Trials

Nutritional Support in Pressure Ulcer Patients

OEST
Start date: February 2010
Phase: N/A
Study type: Interventional

Pressure ulcers are frequently associated with malnutrition. Previous studies have reported that nutritional support can improve the healing rate of pressure ulcers but no attention has been clearly given to the nutritional status of the patient treated. Moreover, other investigators have suggested the additional healing power of some nutrients. Unfortunately, previous results have been unpowered by small sample size, poor monitoring of compliance to treatments and the confounding effect of other nutrients. The investigators aimed to test the effect and additional benefits of several micronutrients delivered through oral nutritional support on the healing rate of pressure ulcers in malnourished patients.

NCT ID: NCT01008254 Completed - Pressure Ulcers Clinical Trials

Interdisciplinary Mobility Approach To Reduction Of Facility-Acquired Pressure Ulcers

TEAM
Start date: September 2009
Phase: Phase 2/Phase 3
Study type: Interventional

Musical reminder will raise compliance with mobility in the long-term care setting and reduce facility-acquired pressure ulcers.

NCT ID: NCT00971048 Completed - Clinical trials for Diabetic Foot Ulcers

Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness Wounds

Start date: September 2009
Phase: N/A
Study type: Interventional

To compare HP828-101 to standard of care for the management of partial or full thickness wounds

NCT ID: NCT00847665 Completed - Pressure Ulcers Clinical Trials

Pressure Ulcer Prevention in Ventilated Patients Using Two Repositioning Regimens

PUPPAS
Start date: February 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare a 2-hour versus every 4-hour turning regimen on the incidence of grade > II pressure ulcers (PU) in patients in ICU on mechanical ventilation ≥ 24h that use alternating-pressure air mattresses (APAMs).

NCT ID: NCT00771238 Completed - Pressure Ulcers Clinical Trials

Pilot Study of Incidence and Change in Existing Pressure Ulcers: TC500 Bed Compared With Standard Beds

Start date: November 2008
Phase: N/A
Study type: Interventional

This pilot study will compare the incidence of pressure ulcers and the change in existing pressure ulcers for patients who are either placed on the new TC500 bed against those placed on the standard ICU bed in the Cardiovascular unit of University of Nebraska Medical Center. Additionally, the cost associated with rental beds will be calculated as well as skin care compliance. Sixty patients will be enrolled (30 per study arm).

NCT ID: NCT00763282 Completed - Clinical trials for Spinal Cord Injuries

Self-Management to Prevent Ulcers in Veterans With SCI (Spinal Cord Injury)

Start date: November 2008
Phase: N/A
Study type: Interventional

Pressure ulcers (PrUs) are the most frequent significant medical complication after spinal cord injury (SCI). PrU prevalence, morbidity, mortality, and recurrence rates are high, and most persons with SCI will have at least one serious PrU during their lifetime. VA costs of treating the almost 3,500 unique Veterans with SCI and a severe ulcer at an SCI Center in FY10 was just under $400 million.

NCT ID: NCT00762138 Terminated - Wounds Clinical Trials

The AutoloGel™ Post-Market Surveillance (TAPS) Program

TAPS
Start date: September 2008
Phase: N/A
Study type: Interventional

AutoloGel™ Post-Market Surveillance Program Purpose:Evaluate the incidence of hematologic and immunologic adverse events, including coagulopathies in patients with wounds to which AutoloGel™ was applied. Design:Prospective, open label, patient registry. Investigator Sites: 3 Enrollment Size: 300 Subject Population: Patients with exuding wounds, such as leg ulcers, pressure ulcers, and diabetic ulcers and for the management of mechanically or surgically-debrided wounds. Primary Objective Safety: Assess the incidence of hematologic (coagulopathies), immunologic (including anaphylaxis) and other adverse events associated with the application of AutoloGel on exuding wounds, such as leg ulcers, pressure ulcers and diabetic ulcers and during the management of mechanically or surgically-debrided wounds. Primary Safety Endpoint: Absence of coagulopathies caused by inhibitors to coagulation Factor V as determined by a significant prolongation of the prothrombin (PT) time and confirmed by severe depletion of Factor V activity with a positive Bethesda Assay for anti-Factor V functional inhibitors.